Dose-Length Product to Effective Dose Conversion Factors for Common Computed Tomography Examinations Based on Canadian Clinical Experience

The 2007 Recommendations of the International Commission on Radiological Protection ICRP publication 103 Ann ICRP 2007; 37:1–332.

1990 Recommendations of the International Commission on Radiological Protection ICRP publication 60 Ann ICRP 1991; 21:1–201.

Huda W. Ogden K.M. Khorasani M.R. Converting dose-length product to effective dose at CT Radiology 2008; 248:995–1003.

European Commission European guidelines on quality criteria for computed tomography. EUR 16262 EN 2000 Office for Official Publication of the European Communities Luxembourg

Deak P.D. Smal Y. Kalendar W.A. Multisection CT protocols: sex- and age-specific conversion factors used to determine effective dose from dose-length product Radiology 2010; 257:158–166.

Christner J.A. Kofler J.M. McCollough C.H. Estimating effective dose for CT using dose-length product compared with using organ doses: consequences of adopting International Commission on Radiological Protection Publication 103 or dual-energy scanning AJR Am J Roentgenol 2010; 194:881–889.

Huda W, Magill D, Wenjun He. CT effective dose per dose length product using ICRP 103 weighting factors. Med Phys 2011;38:1261–5.

ImPACT. ImPACT's CT dosimetry tool. CTDosimetry version 1.0.4. Available at: http://www.impactscan.org/ctdosimetry.htm. Accessed January 16, 2012.

Jones D.G. Shrimpton P.C. Normalised organ doses for x-ray computed tomography calculated using Monte Carlo techniques NRPB-SR250 1993 National Radiological Protection Board Publication Chilton, England

Martin C.J. Effective dose: how should it be applied to medical exposure? Br J Radiol 2007; 80:639–647.

van Straten M. Deak P. Shrimpton P.C. The effect of angular and longitudinal tube current modulation on the estimation of organ and effective doses in x-ray computed tomography Med Phys 2009; 36:4881–4889.